Statistics

Total Visits

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial7

Select a period of time:

Number of views in the range

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial5

Views

Views
December 20230
January 20241
February 20240
March 20242
April 20240
May 20242
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Ashburn1
Boardman1